Angiotensin I converting enzyme polymorphism in humans with age- associated memory impairment: Relationship with cognitive performance

Neuroscience Letters

Volumn 290, Issue 3, 2000, Pages 177-180

  Bartrés Faz, David ^a   Junqué, Carme ^a   Clemente, Imma C ^a   López Alomar, Antoni ^b   Valveny, Neus ^b   López Guillén, Anselm ^c   López, Teresa ^d   Cubells, Jesús ^d   Moral, Pedro ^b  

^a Psychobiology Unit   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c CAP Rambla   (Spain)

^d CAP Lepanto   (Spain)

Author keywords

ACE; Age associated memory impairment; Elder, Memory; Neuropsychology; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; AMNESIA; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FEMALE; FRONTAL LOBE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RECALL; SENILE DEMENTIA; SEX DIFFERENCE; TASK PERFORMANCE;

AGE FACTORS; AGED; AGING; ALLELES; COGNITION; GENOTYPE; HUMANS; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PSYCHOMOTOR PERFORMANCE; RISK FACTORS;

EID: 0343878843     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01349-5     Document Type: Article

References (19)

1. Amar K., Macgowan S., Wilcock G., Lewis T., Scott M. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population. Int. J. Geriatr. Psychiatry. 13:1998;585-590.
2. Amouyel P., Richard F., Cotel D., Amant C., Codron V., Helbecque N. The deletion of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:1996;203-205.
3. Barnes J.M., Barnes N.M., Costall B., Horovitz Z.P., Ironside J.W., Naylor R.J., Williams T.J. Angiotensin II inhibits acetylcholine release form human temporal cortex: implications for cognition. Brain Res. 507:1990;341-343.
4. Bartrés-Faz D., Junqué C., López A., Valveny N., Moral P., Gálvez E., López T., Moya A., Navarro J.L., Clemente I. Apo E influences declarative and procedural learning in age-associated memory impairment. NeuroReport. 10:1999;2923-2927.
5. Boone K.B., Miller B.L., Lesser I.M., Mehringer M., Hill-Gutierrez E., Goldberg M.A., Berman N.G. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. Arch. Neurol. 49:1992;549-554.
6. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J., Arveiler D., Luc G., Bard J., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
7. Crook T.H., Bartus R.T., Ferris S.H., Whitehouse P., Cohen G.D., Gershon S. Age-Associated Memory Impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Dev. Neuropsychol. 2:1986;261-276.
8. Farrer L., Sherbatich T., Keryanov S.A., Korovaitseva G.I., Rogaeva E.A., Petruk S., Premkumar S., Moliaka Y., Qiang Song Y., Pey Y., Sato C., Selezneva N.D., Voskresenskaya S., Golimbet V., Sorbi S., Duara R., Gavrilova S., George-Hyslop P.H., Rogaev E.I. Association between angiotensin-converting enzyme and Alzheimer's disease. Arch. Neurol. 57:2000;210-214.
9. Hu J., Miyatake F., Aizu Y., Nakagawa H., Nakamura S., Tamaoka A., Takahash R., Urakami K., Shoji M. Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci. Lett. 277:1999;65-67.
10. Junqué C., Pujol J., Vendrell P., Bruna O., Jódar M., Ribas J.C., Viñas J., Capdevila A., Martí-Vilalta J.L. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch. Neurol. 47:1990;151-156.
11. Kehoe P.G., Russ C., Mcllroy S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B., Liddlell M., Plomin R., Dynan K., Williams N., Neal J., Cairns N.J., Wilcock G., Passmore P., Lovestone S., Williams J., Owen M.J. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet. 21:1999;71-72.
12. Lezak M.D. Neuropsychologial Assessment. 1995;Oxford University Press, New York.
13. Markus H.S., Barley J., Lunt R., Bland M., Jeffery S., Carter N.D., Brown M.M. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke. 26:1995;1329-1333.
14. Nakata Y., Katsuya T., Rakugi H., Takami S., Sato N., Kamide K., Ohishi M., Miki T., Higaki J., Ogihara T. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Stroke. 10:1997;1391-1395.
15. Palumbo B., Cadini D., Nocentini G., Filipponi E., Fravolini M.L., Senin U. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci. Lett. 267:1999;97-100.
16. Pantoni L., Garcia J.H. The significance of cerebral white matter abnormalities 100 years after binswanger's report. a review. Stroke. 26:1995;1293-1301.
17. Richard F., Berr C., Amant C., Helbecque N., Amouyel P., Alpérovitch A. Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. Neurobiol. Aging. 21:2000;75-80.
18. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and expression of Alzheimer disease: the Nun Study. J. Am. Med. Assoc. 277:1997;813-817.
19. Valveny N., Esteban E., Kandil M., Moral P. APO E polymorphism in Spanish and Moroccan populations. Clin. Genet. 51:1997;354-356.